Commonwealth Equity Services’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145K | Buy |
54,856
+24,334
| +80% | +$64.3K | ﹤0.01% | 3997 |
|
|
2025
Q1 | $92K | Buy |
30,522
+1,567
| +5% | +$4.72K | ﹤0.01% | 4004 |
|
|
2024
Q4 | $74K | Buy |
28,955
+8,380
| +41% | +$21.4K | ﹤0.01% | 3947 |
|
|
2024
Q3 | $77K | Buy |
20,575
+2,400
| +13% | +$8.98K | ﹤0.01% | 3897 |
|
|
2024
Q2 | $115K | Buy |
18,175
+7,135
| +65% | +$45.1K | ﹤0.01% | 3789 |
|
|
2024
Q1 | $59K | Buy |
11,040
+855
| +8% | +$4.57K | ﹤0.01% | 3868 |
|
|
2023
Q4 | $51K | Buy |
+10,185
| New | +$51K | ﹤0.01% | 3755 |
|
|
2022
Q2 | – | Sell |
-13,108
| Closed | -$73K | – | 3735 |
|
|
2022
Q1 | $73K | Buy |
+13,108
| New | +$73K | ﹤0.01% | 3540 |
|